Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis

被引:24
|
作者
Tatar, Ovidiu [1 ]
Thompson, Erika [2 ]
Naz, Anila [1 ]
Perez, Samara [1 ,3 ]
Shapiro, Gilla K. [1 ,3 ]
Wade, Kristina [1 ]
Zimet, Gregory [4 ]
Gilca, Vladimir [5 ]
Janda, Monika [6 ]
Kahn, Jessica [7 ]
Daley, Ellen [8 ]
Rosberger, Zeev [1 ,3 ]
机构
[1] Jewish Gen Hosp, Lady Davis Inst Med Res, 4333 Cote Ste Catherine Rd, Montreal, PQ H3T 1E4, Canada
[2] Univ North Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Behav & Hlth Syst, 3500 Camp Bowie,EAD 709M, Ft Worth, TX 76107 USA
[3] McGill Univ, Dept Psychol, 2001 McGill Coll, Montreal, PQ, Canada
[4] Indiana Univ Sch Med, Sect Adolescent Med, 410 West 10th St,HS 1001, Indianapolis, IN 46202 USA
[5] Inst Natl Sante Publ Quebec, 945 Wolfe Ave, Quebec City, PQ G1V 5B3, Canada
[6] Queensland Univ Technol, Fac Hlth, Brisbane, Qld, Australia
[7] Univ Cincinnati Ohio, Cincinnati Childrens Hosp Med Ctr, Div Adolescent & Transit Med, MLC 4000,3333 Burnet Ave, Cincinnati, OH 45229 USA
[8] Univ S Florida, Dept Community & Family Hlth, 13201 Bruce B Downs Blvd,MDC 56, Tampa, FL 33612 USA
关键词
Human papillomavirus; Uterine Cervical Neoplasms; Mass Screening; Psychology; Human Papillomavirus DNA Tests; Review; Mixed methods; Barriers; Facilitators; Psychosocial; INTRAEPITHELIAL NEOPLASIA; QUALITY-ASSURANCE; DECISION-MAKING; FOLLOW-UP; KNOWLEDGE; WOMEN; INFORMATION; VACCINATION; PREFERENCES; PREDICTORS;
D O I
10.1016/j.ypmed.2018.08.034
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards implementation of an HPV-DNA test, which is more sensitive than Pap cytology in detecting high-risk lesions and offers greater protection against invasive cervical carcinomas. Based on these results, many countries are recommending and implementing HPV testing-based screening programs. Understanding what factors (e.g., knowledge, attitudes) will impact on HPV test acceptability by women is crucial for ensuring adequate public health practices to optimize cervical screening uptake. We used mixed methods research synthesis to provide a categorization of the relevant factors related to HPV primary screening for cervical cancer and describe their influence on women's acceptability of HPV testing. We searched Medline, Embase, PsycINFO, CINAHL, Global Health and Web of Science for journal articles between January 1, 1980 and October 31, 2017 and retained 22 empirical articles. Our results show that while most factors associated with HPV test acceptability are included in the Health Belief Model and/or Theory of Planned Behavior (e.g., attitudes, knowledge), other important factors are not encompassed by these theoretical frameworks (e.g., health behaviors, negative emotional reactions related to HPV testing). The direction of influence of psychosocial factors on HPV test acceptability was synthesized based on 14 quantitative studies as: facilitators (e.g., high perceived HPV test benefits), barriers (e.g., negative attitudes towards increased screening intervals), contradictory evidence (e.g., sexual history) and no impact (e.g., high perceived severity of HPV infection). Further population-based studies are needed to confirm the impact of these factors on HPV-based screening acceptability.
引用
收藏
页码:40 / 50
页数:11
相关论文
共 50 条
  • [1] Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening
    Liao, Yiqun
    Li, Qingge
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (10) : 857 - 862
  • [2] Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings
    Valencak, Anja Ostrbenk
    Sterbenc, Anja
    Seme, Katja
    Poljak, Mario
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (01)
  • [3] Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening
    Tatar, Ovidiu
    Wade, Kristina
    McBride, Emily
    Thompson, Erika
    Head, Katharine J.
    Perez, Samara
    Shapiro, Gilla K.
    Waller, Jo
    Zimet, Gregory
    Rosberger, Zeev
    JOURNAL OF WOMENS HEALTH, 2020, 29 (03) : 390 - 405
  • [4] Predictors of Human Papillomavirus (HPV) Vaccine Acceptability Among Physicians, Their Knowledge on Cervical Cancer, and Factors Influencing Their Decision to Recommend It
    Alosaimi, Bandar
    Fallatah, Deema, I
    Abd ElHafeez, Samar
    Saleeb, Marina
    Alshanbari, Huda M.
    Awadalla, Maaweya
    Ahram, Mamoun
    Khalil, Mohammad Adnan
    JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 5177 - 5188
  • [5] Human papillomavirus test with cytology triage in organized screening for cervical cancer
    Veijalainen, Olga
    Kares, Saara
    Kujala, Paula
    Tirkkonen, Mika
    Vuento, Risto
    Kholova, Ivana
    Luukkaala, Tiina
    Osuala, Veronika
    Maenpaa, Johanna
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (11) : 1220 - 1227
  • [6] Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening
    Chatzistamatiou, Kimon
    Vrekoussis, Thomas
    Tsertanidou, Athena
    Moysiadis, Theodoros
    Mouchtaropoulou, Evangelia
    Pasentsis, Konstantinos
    Kitsou, Anastasia
    Moschaki, Viktoria
    Ntoula, Maria
    Zempili, Paraskevi
    Halatsi, Despina
    Truva, Theoni
    Piha, Vaia
    Agelena, Georgia
    Daponte, Alexandros
    Vanakara, Polyxeni
    Paschopoulos, Minas
    Stefos, Theodoros
    Lymberis, Vasilis
    Kontomanolis, Emmanuel N.
    Makrigiannakis, Antonis
    Deligeoroglou, Efthimios
    Panoskaltsis, Theodoros
    Adonakis, George
    Michail, George
    Stamatopoulos, Kostas
    Agorastos, Theodoros
    JOURNAL OF WOMENS HEALTH, 2020, 29 (11) : 1447 - 1456
  • [7] Primary human papillomavirus DNA screening for cervical cancer prevention: Can the screening interval be safely extended?
    Vink, Margaretha A.
    Bogaards, Johannes A.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (02) : 420 - 427
  • [8] Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
    Agorastos, Theodoros
    Chatzistamatiou, Kimon
    Katsamagkas, Taxiarchis
    Koliopoulos, George
    Daponte, Alexandros
    Constantinidis, Theocharis
    Constantinidis, Theodoros C.
    PLOS ONE, 2015, 10 (03):
  • [9] Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing
    Demarco, Maria
    Carter-Pokras, Olivia
    Hyun, Noorie
    Castle, Philip E.
    He, Xin
    Dallal, Cher M.
    Chen, Jie
    Gage, Julia C.
    Befano, Brian
    Fetterman, Barbara
    Lorey, Thomas
    Poitras, Nancy
    Raine-Bennett, Tina R.
    Wentzensen, Nicolas
    Schiffman, Mark
    JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (05)
  • [10] Primary cervical cancer screening with an HPV mRNA test: a prospective cohort study
    Sorbye, Sveinung Wergeland
    Fismen, Silje
    Gutteberg, Tore Jarl
    Mortensen, Elin Synnove
    Skjeldestad, Finn Egil
    BMJ OPEN, 2016, 6 (08):